Heron Gross Profit vs Net Interest Income Analysis

HRTX Stock

USD 2.52 0.00 0.00%

Heron Therapeuti financial indicator trend analysis is much more than just examining Heron Therapeuti latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Heron Therapeuti is a good investment. Please check the relationship between Heron Therapeuti Gross Profit and its Net Interest Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Gross Profit vs Net Interest Income

Gross Profit vs Net Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Heron Therapeuti Gross Profit account and Net Interest Income. At this time, the significance of the direction appears to have strong relationship.

The correlation between Heron Therapeuti's Gross Profit and Net Interest Income is 0.7. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Net Interest Income in the same time period over historical financial statements of Heron Therapeuti, assuming nothing else is changed. The correlation between historical values of Heron Therapeuti's Gross Profit and Net Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Heron Therapeuti are associated (or correlated) with its Net Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Interest Income has no effect on the direction of Gross Profit i.e., Heron Therapeuti's Gross Profit and Net Interest Income go up and down completely randomly.

Correlation Coefficient

0.7

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Heron Therapeuti minus its cost of goods sold. It is profit before Heron Therapeuti operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most indicators from Heron Therapeuti's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Heron Therapeuti current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.At this time, Heron Therapeuti's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 1.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 28.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	258.2M	227.5M	172.6M	181.2M
Cost Of Revenue	46.0M	54.9M	65.1M	68.4M

Total Operating Expenses Cost Of Revenue

Heron Therapeuti fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Inventory	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock	Other Liab
Total Assets		0.23	0.87	0.86	0.78	0.76	0.07	-0.65	0.28	0.66	0.23	0.91	0.78	0.64	0.0	0.77	0.5	0.66	1.0	0.35	0.71	0.87	0.35	-0.09	-0.06	-0.7
Short Long Term Debt Total	0.23		0.58	0.48	-0.42	0.62	0.91	-0.86	-0.23	0.77	0.87	-0.15	0.64	0.85	0.93	0.77	0.95	0.77	0.15	-0.07	0.77	0.2	-0.09	0.0	0.22	-0.52
Other Current Liab	0.87	0.58		0.96	0.42	0.91	0.4	-0.9	0.17	0.85	0.47	0.63	0.91	0.89	0.33	0.96	0.8	0.89	0.84	0.37	0.9	0.83	0.23	-0.09	0.03	-0.81
Total Current Liabilities	0.86	0.48	0.96		0.46	0.78	0.25	-0.81	0.32	0.72	0.36	0.66	0.9	0.81	0.18	0.88	0.73	0.75	0.84	0.6	0.8	0.75	0.46	-0.12	-0.03	-0.8
Total Stockholder Equity	0.78	-0.42	0.42	0.46		0.31	-0.51	-0.04	0.39	0.13	-0.32	0.95	0.29	0.04	-0.57	0.21	-0.15	0.11	0.83	0.31	0.16	0.67	0.34	-0.07	-0.19	-0.31
Property Plant And Equipment Net	0.76	0.62	0.91	0.78	0.31		0.46	-0.88	0.11	0.97	0.6	0.49	0.75	0.84	0.44	0.91	0.78	0.94	0.7	0.11	0.9	0.87	-0.14	-0.02	0.09	-0.75
Net Debt	0.07	0.91	0.4	0.25	-0.51	0.46		-0.7	-0.61	0.6	0.77	-0.29	0.51	0.7	0.89	0.6	0.81	0.63	0.0	-0.36	0.65	0.06	-0.2	0.05	0.27	-0.37
Retained Earnings	-0.65	-0.86	-0.9	-0.81	-0.04	-0.88	-0.7		0.0	-0.92	-0.74	-0.3	-0.88	-0.98	-0.7	-0.98	-0.97	-0.94	-0.58	-0.16	-0.95	-0.62	-0.06	0.03	-0.15	0.72
Cash	0.28	-0.23	0.17	0.32	0.39	0.11	-0.61	0.0		0.04	-0.14	0.39	0.03	-0.02	-0.32	0.06	-0.09	-0.01	0.3	0.72	-0.06	0.25	0.3	-0.12	-0.21	-0.11
Non Current Assets Total	0.66	0.77	0.85	0.72	0.13	0.97	0.6	-0.92	0.04		0.79	0.34	0.74	0.86	0.61	0.91	0.87	0.92	0.59	0.03	0.93	0.75	-0.15	0.01	0.13	-0.73
Non Currrent Assets Other	0.23	0.87	0.47	0.36	-0.32	0.6	0.77	-0.74	-0.14	0.79		-0.1	0.49	0.67	0.84	0.66	0.81	0.62	0.15	-0.15	0.75	0.28	-0.14	0.06	0.18	-0.47
Cash And Short Term Investments	0.91	-0.15	0.63	0.66	0.95	0.49	-0.29	-0.3	0.39	0.34	-0.1		0.5	0.3	-0.35	0.46	0.13	0.33	0.94	0.38	0.37	0.77	0.42	-0.11	-0.17	-0.46
Net Receivables	0.78	0.64	0.91	0.9	0.29	0.75	0.51	-0.88	0.03	0.74	0.49	0.5		0.9	0.41	0.91	0.83	0.81	0.75	0.35	0.89	0.58	0.39	-0.04	0.13	-0.83
Common Stock Shares Outstanding	0.64	0.85	0.89	0.81	0.04	0.84	0.7	-0.98	-0.02	0.86	0.67	0.3	0.9		0.69	0.98	0.96	0.94	0.59	0.16	0.91	0.56	0.08	-0.07	0.15	-0.7
Non Current Liabilities Total	0.0	0.93	0.33	0.18	-0.57	0.44	0.89	-0.7	-0.32	0.61	0.84	-0.35	0.41	0.69		0.58	0.79	0.61	-0.08	-0.32	0.59	0.0	-0.29	0.11	0.33	-0.22
Other Stockholder Equity	0.77	0.77	0.96	0.88	0.21	0.91	0.6	-0.98	0.06	0.91	0.66	0.46	0.91	0.98	0.58		0.92	0.94	0.71	0.21	0.95	0.71	0.11	-0.05	0.12	-0.75
Total Liab	0.5	0.95	0.8	0.73	-0.15	0.78	0.81	-0.97	-0.09	0.87	0.81	0.13	0.83	0.96	0.79	0.92		0.88	0.43	0.12	0.9	0.45	0.08	-0.04	0.17	-0.69
Property Plant And Equipment Gross	0.66	0.77	0.89	0.75	0.11	0.94	0.63	-0.94	-0.01	0.92	0.62	0.33	0.81	0.94	0.61	0.94	0.88		0.59	0.06	0.89	0.68	-0.16	-0.01	0.18	-0.73
Total Current Assets	1.0	0.15	0.84	0.84	0.83	0.7	0.0	-0.58	0.3	0.59	0.15	0.94	0.75	0.59	-0.08	0.71	0.43	0.59		0.38	0.64	0.84	0.4	-0.09	-0.08	-0.67
Short Term Debt	0.35	-0.07	0.37	0.6	0.31	0.11	-0.36	-0.16	0.72	0.03	-0.15	0.38	0.35	0.16	-0.32	0.21	0.12	0.06	0.38		0.08	0.22	0.68	-0.14	-0.17	-0.39
Inventory	0.71	0.77	0.9	0.8	0.16	0.9	0.65	-0.95	-0.06	0.93	0.75	0.37	0.89	0.91	0.59	0.95	0.9	0.89	0.64	0.08		0.68	0.08	0.01	0.15	-0.77
Other Current Assets	0.87	0.2	0.83	0.75	0.67	0.87	0.06	-0.62	0.25	0.75	0.28	0.77	0.58	0.56	0.0	0.71	0.45	0.68	0.84	0.22	0.68		0.0	-0.03	-0.05	-0.61
Accounts Payable	0.35	-0.09	0.23	0.46	0.34	-0.14	-0.2	-0.06	0.3	-0.15	-0.14	0.42	0.39	0.08	-0.29	0.11	0.08	-0.16	0.4	0.68	0.08	0.0		-0.17	-0.2	-0.25
Common Stock Total Equity	-0.09	0.0	-0.09	-0.12	-0.07	-0.02	0.05	0.03	-0.12	0.01	0.06	-0.11	-0.04	-0.07	0.11	-0.05	-0.04	-0.01	-0.09	-0.14	0.01	-0.03	-0.17		0.95	0.16
Common Stock	-0.06	0.22	0.03	-0.03	-0.19	0.09	0.27	-0.15	-0.21	0.13	0.18	-0.17	0.13	0.15	0.33	0.12	0.17	0.18	-0.08	-0.17	0.15	-0.05	-0.2	0.95		0.05
Other Liab	-0.7	-0.52	-0.81	-0.8	-0.31	-0.75	-0.37	0.72	-0.11	-0.73	-0.47	-0.46	-0.83	-0.7	-0.22	-0.75	-0.69	-0.73	-0.67	-0.39	-0.77	-0.61	-0.25	0.16	0.05

Click cells to compare fundamentals

Heron Therapeuti Account Relationship Matchups

Heron Therapeuti fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	512.8M	353.6M	305.7M	251.0M	222.5M	233.6M
Short Long Term Debt Total	19.8M	24.6M	159.5M	157.5M	179.6M	188.6M
Other Current Liab	86.4M	91.9M	64.8M	76.4M	73.4M	77.0M
Total Current Liabilities	96.7M	102.5M	71.1M	82.4M	79.7M	83.7M
Total Stockholder Equity	403.8M	236.5M	77.6M	13.6M	(34.0M)	(32.3M)
Property Plant And Equipment Net	33.4M	39.0M	33.6M	29.8M	25.6M	26.9M
Net Debt	(52.1M)	(80.5M)	69.0M	142.1M	151.0M	158.5M
Retained Earnings	(1.2B)	(1.4B)	(1.6B)	(1.8B)	(1.9B)	(1.8B)
Cash	71.9M	105.1M	90.5M	15.4M	28.7M	27.8M
Non Current Assets Total	33.7M	39.4M	51.3M	45.5M	33.7M	35.4M
Cash And Short Term Investments	391.0M	208.5M	157.6M	84.9M	80.4M	60.9M
Net Receivables	39.9M	41.9M	35.5M	52.0M	60.1M	63.1M
Common Stock Shares Outstanding	81.8M	90.8M	98.5M	108.9M	138.1M	145.0M
Liabilities And Stockholders Equity	512.8M	353.6M	305.7M	251.0M	222.5M	233.6M
Non Current Liabilities Total	12.2M	14.6M	157.1M	155.0M	176.8M	185.6M
Other Stockholder Equity	1.6B	1.6B	1.7B	1.8B	1.9B	2.0B
Total Liab	108.9M	117.1M	228.1M	237.4M	256.5M	269.3M
Property Plant And Equipment Gross	33.4M	39.0M	33.6M	29.8M	42.6M	44.8M
Total Current Assets	479.1M	314.2M	254.4M	205.4M	188.8M	198.2M
Accumulated Other Comprehensive Income	85K	257K	(6K)	(19K)	13K	13.7K
Short Term Debt	7.6M	10.1M	2.4M	2.7M	3.1M	3.3M
Inventory	25.0M	41.9M	48.4M	54.6M	42.1M	44.2M
Other Current Assets	23.2M	22.0M	13.0M	14.0M	6.1M	4.4M
Accounts Payable	2.8M	525K	3.8M	3.2M	3.2M	3.2M
Common Stock Total Equity	782K	903K	913K	1.0M	1.2M	658.0K
Common Stock	903K	913K	1.0M	1.2M	1.5M	1.6M
Other Assets	346K	16.6M	17.7M	15.7M	18.1M	19.0M
Short Term Investments	319.1M	103.4M	67.0M	69.5M	51.7M	55.8M
Property Plant Equipment	19.6M	22.7M	33.6M	29.8M	34.3M	36.0M
Net Tangible Assets	403.8M	236.5M	77.6M	13.6M	15.6M	14.8M
Retained Earnings Total Equity	(960.7M)	(1.2B)	(1.4B)	(1.6B)	(1.5B)	(1.4B)
Capital Surpluse	1.3B	1.6B	1.6B	1.7B	1.9B	2.0B
Short Long Term Debt	28.7M	4.6M	5.6M	7.1M	8.1M	8.3M
Net Invested Capital	409.5M	243.5M	226.7M	162.9M	139.8M	196.2M
Net Working Capital	382.4M	211.7M	183.4M	123.1M	109.1M	170.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock:

How To Invest In Heron

Details

Is Heron Stock a good investment?

Details

What is Heron Therapeuti's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Heron Stock analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

	Stocks Directory Find actively traded stocks across global markets
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges

Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.80)

Revenue Per Share

0.92

Quarterly Revenue Growth

0.14

Return On Assets

(0.25)

Return On Equity

(24.09)

The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heron Gross Profit vs Net Interest Income Analysis

Gross Profit vs Net Interest Income

Gross Profit vs Net Interest Income Correlation Analysis

Correlation Coefficient

Gross Profit

Net Interest Income

Heron Therapeuti fundamental ratios Correlations

Heron Therapeuti Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Heron Therapeuti fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Heron Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Other Stockholder Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.97	Property Plant And Equipment Net
Total Current Liabilities	+ 0.96	Other Current Liab
Other Stockholder Equity	+ 0.96	Other Current Liab
Total Liab	+ 0.96	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.98	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Inventory	- 0.95	Retained Earnings
Property Plant And Equipment Gross	- 0.94	Retained Earnings
Non Current Assets Total	- 0.92	Retained Earnings